肺结核患者治疗成功的相关因素:从NTIP记录中探索
Sasicha Kwangdam1, Sulida Toekasem1, Wanpen Yingyuat2
1Faculty of Health and Sports Science, Thaksin University Phatthalung Campus, Thailand.
Studies in health technology and informatics
|July 1, 2025
概括
这项研究发现,80.98%的肺结核患者获得了治疗成功. 成功治疗结核病的关键因素包括更高的BMI和遵守医疗预约.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 肺结核 (TB) 仍然是一个重大的全球卫生挑战.
- 了解影响结核病治疗成功的因素对于改善患者的治疗结果和控制疾病传播至关重要.
研究的目的:
- 为了确定肺结核患者治疗成功率.
- 确定与成功结核病治疗相关的因素.
主要方法:
- 进行了一项横截面分析研究.
- 分析了从2018年到2023年在Pak Phanang医院治疗的305名肺结核患者的数据.
- 二元逻辑回归被用来识别影响治疗成功的因素.
主要成果:
- 结核病治疗的整体成功率为80.98%.
- 与成功治疗显著相关的因素包括更高的体重指数 (BMI),遵守医疗预约,艾滋病毒查史,结核病住院和CD4检测.
- 在19.02%的患者中观察到不成功的治疗.
结论:
- 改善患者管理,确保持续监测,促进患者遵守规则和教育对于提高结核病治疗结果至关重要.
- 加强这些干预措施可以帮助降低治疗失败率并改善公共卫生.
- 专注于已识别的因素可以导致更好的肺结核管理.
更多相关视频
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.9K
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
8.7K
相关概念视频
Pulmonary Tuberculosis V
246
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
246
Pulmonary Tuberculosis IV
207
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
207
Pulmonary Tuberculosis I
332
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
332
Pulmonary Tuberculosis III
452
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
452
Pulmonary Tuberculosis II
381
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
381
Pneumonia IV: Management
456
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
456
